AdvaMed® submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies for skin substitute products as used and paid for in the outpatient…
In advance of CMS’ release of the proposed End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) rule, AdvaMed® submitted a letter focused on coverage and payment policies for ESRD patients.
AdvaMed® submitted comments on the Centers for Medicare and Medicaid Services’ Advance Notice of Methodological Changes for Calendar Year 2023 for Medicare Advantage Capitation Rate and Part C and Part…
AdvaMed® submitted a response to a U.S. House of Representatives Healthy Futures Task Force, Modernization Subcommittee (the Modernization Subcommittee) Request for Information (RFI) on the utilization of wearable technologies, expansion…
AdvaMed® submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies addressed under the Physician Fee Schedule (PFS) in anticipation of upcoming Calendar…
In advance of annual rulemaking, AdvaMed® submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies addressed under the Hospital Outpatient Prospective Payment…
In advance of annual rulemaking, AdvaMed® submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies addressed under the Hospital Inpatient Prospective Payment…
AdvaMed® submitted a response to a Centers for Medicare and Medicaid Services (CMS) Request for Information (RFI) on potential changes to the requirements transplant programs, organ procurement organizations, and end-stage…
Participate in this letter writing campaign to further ongoing advocacy efforts to improve and advance The VALID Act, comprehensive diagnostics regulatory reform legislation.
AdvaMedDx® wrote to affirm our commitment to make modernization of the regulatory framework for IVCTs a reality.